InvestorsHub Logo

rafunrafun

06/25/20 4:21 PM

#282784 RE: Chris2125 #282782

Wow! But WTF does this mean?

On the other hand, since it does not have patent protection, it could be manufactured by any laboratory,"

zmanindc

06/25/20 4:21 PM

#282785 RE: Chris2125 #282782

This actually makes me angry, you have a Covid test in Argentina and yet, almost a year after reduce-it results Amarin has not partnered, nor filed for CVD risk reduction in Argentina. I have been harping on them for awhile on this. It’s ok to drag out an EU decision if you are looking to sell the company but you create more shareholder value if V is available everywhere.

funnygi2

06/25/20 5:15 PM

#282796 RE: Chris2125 #282782

So this was announced May 25 (unless that's a typo and it's from today?)

If it's from a month ago..."The study is currently being evaluated by Argentine regulatory authorities for approval..." Any updates?

MateoPaisa

06/25/20 5:24 PM

#282799 RE: Chris2125 #282782

Why does that read like a 10th grade science paper?. Im calling BS

studythosestocks

06/25/20 11:13 PM

#282853 RE: Chris2125 #282782

Nice find Chris.

studythosestocks

06/26/20 10:58 AM

#282917 RE: Chris2125 #282782

A couple of interesting points I found on the study:
1. Very quick enrollment where Dr Diaz feels confident that the 1500 studied individuals will be enrolled within a month
2. Two month study
3. Randomized and placebo controlled
No guarantees but I could see this study completed and possibly reported by end of year? I guess we’ll see.
Could be another huge revelation in the benefits of V if successful. 30% would be incredible if this doctors assumptions come to fruition.